Avion Wealth’s Alnylam Pharmaceuticals ALNY Stock Holding History

Avion Wealth’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7K	Sell	29 -3	-9%	-$763	﹤0.01%	663
2026 Q2	$9K	Sell	32 -16	-33%	-$4.83K	﹤0.01%	619
2026 Q1	$15K	Buy	48 +15	+45%	+$5.1K	﹤0.01%	386
2025 Q4	$13K	Sell	33 -4	-11%	-$1.77K	﹤0.01%	420
2025 Q3	$16K	Sell	37 -1	-3%	-$407	﹤0.01%	368
2025 Q2	$12K	Buy	38 +20	+111%	+$5.53K	﹤0.01%	410
2025 Q1	$4K	Hold	18	–	–	﹤0.01%	566
2024 Q4	$4K	Sell	18 -3	-14%	-$789	﹤0.01%	564
2024 Q3	$5K	Buy	21 +6	+40%	+$1.56K	﹤0.01%	506
2024 Q2	$3K	Buy	15 +9	+150%	+$1.42K	﹤0.01%	538
2024 Q1	$1K	Hold	6	–	–	﹤0.01%	829
2023 Q4	$1K	Buy	6 +1	+20%	+$170	﹤0.01%	664
2023 Q3	$0	Buy	5 +2	+67%	+$382	﹤0.01%	788
2023 Q2	$0	Buy	+3	New	+$595	﹤0.01%	698

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Avion Wealth's ALNY Position: Q3 2026 in Review

Avion Wealth reduced its Alnylam Pharmaceuticals (ALNY) stake by 9.4% in Q3 2026, selling an estimated $763 and leaving 29 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #663.

Avion Wealth first reported a position in ALNY in Q2 2023 and has held it in 14 quarters since. The position peaked at $16K in Q3 2025. 403 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

Avion Wealth held 29 shares of Alnylam Pharmaceuticals worth $7K as of Q3 2026.
Avion Wealth sold 3 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $763.
Alnylam Pharmaceuticals made up ﹤0.01% of Avion Wealth's portfolio in Q3 2026, its #663 holding.
Avion Wealth first reported a position in Alnylam Pharmaceuticals in Q2 2023 and has held it in 14 quarters since.
Avion Wealth's Alnylam Pharmaceuticals position peaked at $16K in Q3 2025.
403 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on Avion Wealth's 13F filing for Q3 2026, filed 4 Nov 2026.